Rigel Pharmaceuticals
RIGL
RIGL
120 hedge funds and large institutions have $187M invested in Rigel Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 43 increasing their positions, 36 reducing their positions, and 11 closing their positions.
Holders
120
Holders Change
–
Holders Change %
0%
% of All Funds
3.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
43
Reduced
36
Closed
11
Calls
$524K
Puts
$242K
Net Calls
+$282K
Net Calls Change
+$255K
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$3.54M |
| 2 |
GTC
2
Ghost Tree Capital
New York
|
$1.78M |
| 3 |
BC
3
Boxer Capital
San Diego,
California
|
$1.56M |
| 4 |
SM
4
Sabby Management
Miami Beach,
Florida
|
$972K |
| 5 |
JGC
5
J. Goldman & Co
New York
|
$1.63M |
